Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.41 USD
-0.01 (-0.70%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.43 +0.02 (1.42%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
APYX 1.41 -0.01(-0.70%)
Will APYX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for APYX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APYX
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Owens & Minor (OMI) Q4 Earnings Surpass Estimates
APYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biote Corp. (BTMD) Reports Q3 Loss, Lags Revenue Estimates
Are Medical Stocks Lagging Apyx Medical (APYX) This Year?
Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates
Other News for APYX
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), LifeMD (LFMD) and Apyx Medical (APYX)
Wall Street Analysts Are Bullish on Top Healthcare Picks
12 Health Care Stocks Moving In Tuesday's After-Market Session